{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Angiotensin", "CCL2", "CXCL8", "Cardiovascular disorders", "Curcumin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34981477", "DateCompleted": {"Year": "2022", "Month": "01", "Day": "05"}, "DateRevised": {"Year": "2022", "Month": "05", "Day": "13"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1007/978-3-030-73234-9_11"], "Journal": {"ISSN": "0065-2598", "JournalIssue": {"Volume": "1328", "PubDate": {"Year": "2021"}}, "Title": "Advances in experimental medicine and biology", "ISOAbbreviation": "Adv Exp Med Biol"}, "ArticleTitle": "The Role of Chemokines in Cardiovascular Diseases and the Therapeutic Effect of Curcumin on CXCL8 and CCL2 as Pathological Chemokines in Atherosclerosis.", "Pagination": {"StartPage": "155", "EndPage": "170", "MedlinePgn": "155-170"}, "Abstract": {"AbstractText": ["Curcumin, as a vegetative flavonoid, has a protective and therapeutic role in various adverse states such as oxidative stress and inflammation. Remedial properties of this component have been reported in the different chronic diseases including cancers (myeloma, pancreatic, breast, colorectal), vitiligo, psoriasis, neuropathic pains, inflammatory disorders (osteoarthritis, uveitis, ulcerative colitis, Alzheimer), cardiovascular conditions, and diabetes.Cardiovascular disorders include atherosclerosis and various manifestations of atherosclerosis such as stroke, and myocardial infarction (MI) is the leading cause of mortality globally. Studies have shown varying expressions of inflammatory and non-inflammatory chemokines and chemokine receptors in cardiovascular disease, which have been highlighted first in this review. The alteration in chemokines secretion and chemokine receptors has an essential role in the pathophysiology of cardiovascular disease. Chemokines as cytokines with low molecular weight (8-12 kDa) mediate white blood cell (WBC) chemotactic reactions, vascular cell migration, and proliferation that induce endothelial dysfunction, atherogenesis, and cardiac hypertrophy.Several studies reported that curcumin could be advantageous in the attenuation of cardiovascular diseases via anti-inflammatory effects and redress of chemokine secretion and chemokine receptors. We present these studies with a focus on two chemokines: CXCL8 (IL-8) and CCL2 (chemoattractant protein 1 or MCP-1). Future research will further elucidate the precise potential of curcumin on chemokines in the adjustment of cardiovascular system activity or curcumin chemokine-based therapies."], "CopyrightInformation": "\u00a9 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, School of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran."}], "LastName": "Hedayati-Moghadam", "ForeName": "Mahdiyeh", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Hosseinian", "ForeName": "Sara", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products & Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Paseban", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, Bam University of Medical Sciences, Bam, Iran."}], "LastName": "Shabgah", "ForeName": "Arezoo Gowhari", "Initials": "AG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, Bam University of Medical Sciences, Bam, Iran."}], "LastName": "Gholizadeh", "ForeName": "Jamshid", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Science and Technology, Quchan Branch, Islamic Azad University, Quchan, Iran."}, {"Identifier": [], "Affiliation": "Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Jamialahmadi", "ForeName": "Tannaz", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Academic Diabetes, Endocrinology and Metabolism, Hull York Medical School, University of Hull, Tehran, Iran."}], "LastName": "Sathyapalan", "ForeName": "Thozhukat", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir."}, {"Identifier": [], "Affiliation": "Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir."}], "LastName": "Sahebkar", "ForeName": "Amirhossein", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Adv Exp Med Biol", "NlmUniqueID": "0121103", "ISSNLinking": "0065-2598"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "CCL2 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Chemokine CCL2"}, {"RegistryNumber": "0", "NameOfSubstance": "Chemokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-8"}, {"RegistryNumber": "IT942ZTH98", "NameOfSubstance": "Curcumin"}], "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Atherosclerosis"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Cardiovascular Diseases"}, {"QualifierName": [], "DescriptorName": "Chemokine CCL2"}, {"QualifierName": [], "DescriptorName": "Chemokines"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Curcumin"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Interleukin-8"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Dahl\u00f6f, B. (2010). Cardiovascular disease risk factors: Epidemiology and risk assessment. The American Journal of Cardiology, 105(1), 3A\u20139A.", "ArticleIdList": ["20102968"]}, {"Citation": "Frangogiannis, N. G. (2014). The inflammatory response in myocardial injury, repair, and remodelling. Nature Reviews Cardiology, 11(5), 255.", "ArticleIdList": ["24663091", "4407144"]}, {"Citation": "Yndestad, A., Dam\u00e5s, J. K., \u00d8ie, E., Ueland, T., Gullestad, L., & Aukrust, P. (2007). Role of inflammation in the progression of heart failure. Current Cardiology Reports, 9(3), 236\u2013241.", "ArticleIdList": ["17470337"]}, {"Citation": "Shinagawa, H., & Frantz, S. (2015). Cellular immunity and cardiac remodeling after myocardial infarction: Role of neutrophils, monocytes, and macrophages. Current Heart Failure Reports, 12(3), 247\u2013254.", "ArticleIdList": ["25721354"]}, {"Citation": "Swirski, F. (2015). Inflammation and repair in the ischaemic myocardium. H\u00e4mostaseologie, 35(01), 34\u201336.", "ArticleIdList": ["25375277"]}, {"Citation": "Leuschner, F., Rauch, P. J., Ueno, T., Gorbatov, R., Marinelli, B., Lee, W. W., et al. (2012). Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. Journal of Experimental Medicine, 209(1), 123\u2013137.", "ArticleIdList": ["22213805", "3260875"]}, {"Citation": "St-Pierre, A. C., Bergeron, J., Pirro, M., Cantin, B., Dagenais, G. R., Despr\u00e9s, J.-P., et al. (2003). Effect of plasma C-reactive protein levels in modulating the risk of coronary heart disease associated with small, dense, low-density lipoproteins in men (The Quebec Cardiovascular Study). The American Journal of Cardiology, 91(5), 555\u2013558.", "ArticleIdList": ["12615259"]}, {"Citation": "Welsh, P., Grassia, G., Botha, S., Sattar, N., & Maffia, P. (2017). Targeting inflammation to reduce cardiovascular disease risk: A realistic clinical prospect? British Journal of Pharmacology, 174(22), 3898\u20133913.", "ArticleIdList": ["28409825", "5660005"]}, {"Citation": "Pirro, M., Schillaci, G., Savarese, G., Gemelli, F., Mannarino, M. R., Siepi, D., et al. (2004). Attenuation of inflammation with short-term dietary intervention is associated with a reduction of arterial stiffness in subjects with hypercholesterolaemia. European Journal of Cardiovascular Prevention & Rehabilitation, 11(6), 497\u2013502."}, {"Citation": "Shimizu, K., Funamoto, M., Sunagawa, Y., Shimizu, S., Katanasaka, Y., Miyazaki, Y., et al. (2019). Anti-inflammatory action of curcumin and its use in the treatment of lifestyle-related diseases. European Cardiology Review, 14(2), 117.", "ArticleIdList": ["31360234", "6659038"]}, {"Citation": "Du, S., Li, Z., Xie, X., Xu, C., Shen, X., Wang, N., et al. (2020). IL-17 stimulates the expression of CCL2 in cardiac myocytes via Act1/TRAF6/p38MAPK-dependent AP-1 activation. Scandinavian Journal of Immunology, 91(1), e12840.", "ArticleIdList": ["31630418"]}, {"Citation": "Lu, W., Zhang, Z., Fu, C., & Ma, G. (2014). Intermediate monocytes lead to enhanced myocardial remodelling in STEMI patients with diabetes. International Heart Journal, 56, 22\u201328.", "ArticleIdList": ["25503660"]}, {"Citation": "Wrigley, B. J., Shantsila, E., Tapp, L. D., & Lip, G. Y. (2013). CD 14++ CD 16+ monocytes in patients with acute ischaemic heart failure. European Journal of Clinical Investigation, 43(2), 121\u2013130.", "ArticleIdList": ["23240665"]}, {"Citation": "Fildes, J. E., Shaw, S. M., Yonan, N., & Williams, S. G. (2009). The immune system and chronic heart failure: Is the heart in control? Journal of the American College of Cardiology, 53(12), 1013\u20131020.", "ArticleIdList": ["19298913"]}, {"Citation": "Baldeviano, G. C., Barin, J. G., Talor, M. V., Srinivasan, S., Bedja, D., Zheng, D., et al. (2010). Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circulation Research, 106(10), 1646\u20131655.", "ArticleIdList": ["20378858"]}, {"Citation": "Fan, Y., Weifeng, W., Yuluan, Y., Qing, K., Yu, P., & Yanlan, H. (2011). Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditis reduces myocardium inflammation. Virology Journal, 8(1), 17.", "ArticleIdList": ["21235788", "3032710"]}, {"Citation": "Hansson, G. K. (2005). Inflammation, atherosclerosis, and coronary artery disease. New England Journal of Medicine, 352(16), 1685\u20131695.", "ArticleIdList": ["15843671"]}, {"Citation": "Blanchet, X., Langer, M., Weber, C., Koenen, R. R., & von Hundelshausen, P. (2012). Touch of chemokines. Frontiers in Immunology, 3, 175.", "ArticleIdList": ["22807925", "3394994"]}, {"Citation": "Rajagopalan, L., & Rajarathnam, K. (2006). Structural basis of chemokine receptor function \u2013 A model for binding affinity and ligand selectivity. Bioscience Reports, 26(5), 325\u2013339.", "ArticleIdList": ["17024562"]}, {"Citation": "Asare, Y., Schmitt, M., & Bernhagen, J. (2013). The vascular biology of macrophage migration inhibitory factor (MIF). Thrombosis and Haemostasis, 109(03), 391\u2013398.", "ArticleIdList": ["23329140"]}, {"Citation": "White, G. E., & Greaves, D. R. (2012). Fractalkine: A survivor\u2019s guide: Chemokines as antiapoptotic mediators. Arteriosclerosis, Thrombosis, and Vascular Biology, 32(3), 589\u2013594.", "ArticleIdList": ["22247260"]}, {"Citation": "Williams, K. J., & Tabas, I. (1995). The response-to-retention hypothesis of early atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 15(5), 551\u2013561.", "ArticleIdList": ["7749869", "2924812"]}, {"Citation": "Boisvert, W. A. (2009). The participation of chemokines in atherosclerosis. Discovery Medicine, 4(23), 288\u2013292."}, {"Citation": "Schober, A. (2008). Chemokines in vascular dysfunction and remodeling. Arteriosclerosis, Thrombosis, and Vascular Biology, 28(11), 1950\u20131959.", "ArticleIdList": ["18818421"]}, {"Citation": "Talavera, D., Castillo, A. M., Dominguez, M., Gutierrez, A. E., & Meza, I. (2004). IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. Journal of General Virology, 85(7), 1801\u20131813.", "ArticleIdList": ["15218164"]}, {"Citation": "De la Sierra, A., & Larrousse, M. (2010). Endothelial dysfunction is associated with increased levels of biomarkers in essential hypertension. Journal of Human Hypertension, 24(6), 373\u2013379.", "ArticleIdList": ["19960026"]}, {"Citation": "Martynowicz, H., Janus, A., Nowacki, D., & Mazur, G. (2014). The role of chemokines in hypertension. Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University, 23(3), 319\u2013325."}, {"Citation": "Blanchet, X., Cesarek, K., Brandt, J., Herwald, H., Teupser, D., Kuechenhoff, H., et al. (2014). Inflammatory role and prognostic value of platelet chemokines in acute coronary syndrome. Thrombosis and Haemostasis, 112(12), 1277\u20131287.", "ArticleIdList": ["25183015"]}, {"Citation": "Zernecke, A., & Weber, C. (2014). Chemokines in atherosclerosis: Proceedings resumed. Arteriosclerosis, Thrombosis, and Vascular Biology, 34(4), 742\u2013750.", "ArticleIdList": ["24436368"]}, {"Citation": "Herder, C., Peeters, W., Illig, T., Baumert, J., De Kleijn, D. P., Moll, F. L., et al. (2011). RANTES/CCL5 and risk for coronary events: Results from the MONICA/KORA Augsburg case-cohort, Athero-Express and CARDIoGRAM studies. PLoS One, 6(12), e25734.", "ArticleIdList": ["22162987", "3232218"]}, {"Citation": "Canou\u00ef-Poitrine, F., Luc, G., Mallat, Z., Machez, E., Bingham, A., Ferrieres, J., et al. (2011). Systemic chemokine levels, coronary heart disease, and ischemic stroke events: The PRIME study. Neurology, 77(12), 1165\u20131173.", "ArticleIdList": ["21849651", "3174064"]}, {"Citation": "Von Hundelshausen, P., Agten, S. M., Eckardt, V., Blanchet, X., Schmitt, M. M., Ippel, H., et al. (2017). Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation. Science Translational Medicine, 9(384)."}, {"Citation": "Kramp, B. K., Sarabi, A., Koenen, R. R., & Weber, C. (2011). Heterophilic chemokine receptor interactions in chemokine signaling and biology. Experimental Cell Research, 317(5), 655\u2013663.", "ArticleIdList": ["21146524"]}, {"Citation": "Saxena, A., Russo, I., & Frangogiannis, N. G. (2016). Inflammation as a therapeutic target in myocardial infarction: Learning from past failures to meet future challenges. Translational Research, 167(1), 152\u2013166.", "ArticleIdList": ["26241027"]}, {"Citation": "Majmudar, M. D., Keliher, E. J., Heidt, T., Leuschner, F., Truelove, J., Sena, B. F., et al. (2013). Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice. Circulation, 127(20), 2038\u20132046.", "ArticleIdList": ["23616627", "3661714"]}, {"Citation": "Hage, C., Micha\u00eblsson, E., Linde, C., Donal, E., Daubert, J.-C., Gan, L.-M., et al. (2017). Inflammatory biomarkers predict heart failure severity and prognosis in patients with heart failure with preserved ejection fraction: A holistic proteomic approach. Circulation. Cardiovascular Genetics, 10(1), e001633.", "ArticleIdList": ["28100627"]}, {"Citation": "Winter, C., Silvestre-Roig, C., Ortega-Gomez, A., Lemnitzer, P., Poelman, H., Schumski, A., et al. (2018). Chrono-pharmacological targeting of the CCL2-CCR2 axis ameliorates atherosclerosis. Cell Metabolism, 28(1), 175\u2013182.e175.", "ArticleIdList": ["29861387"]}, {"Citation": "Soehnlein, O., Drechsler, M., D\u00f6ring, Y., Lievens, D., Hartwig, H., Kemmerich, K., et al. (2013). Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes. EMBO Molecular Medicine, 5(3), 471\u2013481.", "ArticleIdList": ["23417922", "3598085"]}, {"Citation": "Boisvert, W. A., Rose, D. M., Johnson, K. A., Fuentes, M. E., Lira, S. A., Curtiss, L. K., et al. (2006). Up-regulated expression of the CXCR2 ligand KC/GRO-\u03b1 in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. The American Journal of Pathology, 168(4), 1385\u20131395.", "ArticleIdList": ["16565511", "1606562"]}, {"Citation": "Szentes, V., Gazdag, M., Szokodi, I., & D\u00e9zsi, C. A. (2018). The role of CXCR3 and associated chemokines in the development of atherosclerosis and during myocardial infarction. Frontiers in Immunology, 9, 1932.", "ArticleIdList": ["30210493", "6119714"]}, {"Citation": "Heller, E. A., Liu, E., Tager, A. M., Yuan, Q., Lin, A. Y., Ahluwalia, N., et al. (2006). Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation, 113(19), 2301\u20132312.", "ArticleIdList": ["16682613"]}, {"Citation": "Doring, Y., Pawig, L., Weber, C., & Noels, H. (2014). The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease. Frontiers in Physiology, 5, 212.", "ArticleIdList": ["24966838", "4052746"]}, {"Citation": "Garc\u00eda-Cuesta, E. M., Santiago, C. A., Vallejo, J., Juarranz, Y., Rodriguez Frade, J. M., & Mellado, M. (2019). The role of the CXCL12/CXCR4/ACKR3 Axis in autoimmune diseases. Frontiers in Endocrinology, 10, 585.", "ArticleIdList": ["31507535", "6718456"]}, {"Citation": "Beygui, F., Collet, J.-P., Benoliel, J.-J., Vignolles, N., Dumaine, R., Barth\u00e9l\u00e9my, O., et al. (2006). Clinical perspective. Circulation, 114(24), 2604\u20132610.", "ArticleIdList": ["17116769"]}, {"Citation": "Saxena, A., Fish, J. E., White, M. D., Yu, S., Smyth, J. W., Shaw, R. M., et al. (2008). Clinical perspective. Circulation, 117(17), 2224\u20132231.", "ArticleIdList": ["18427137", "2743260"]}, {"Citation": "Goldstone, A. B., Burnett, C. E., Cohen, J. E., Paulsen, M. J., Eskandari, A., Edwards, B. E., et al. (2018). SDF 1-alpha attenuates myocardial injury without altering the direct contribution of circulating cells. Journal of Cardiovascular Translational Research, 11(4), 274\u2013284.", "ArticleIdList": ["29468554", "6103912"]}, {"Citation": "Zernecke, A., Bidzhekov, K., Noels, H., Shagdarsuren, E., Gan, L., Denecke, B., et al. (2009). Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Science Signaling, 2(100), ra81\u2013ra81.", "ArticleIdList": ["19996457"]}, {"Citation": "Liehn, E. A., Tuchscheerer, N., Kanzler, I., Drechsler, M., Fraemohs, L., Schuh, A., et al. (2011). Double-edged role of the CXCL12/CXCR4 axis in experimental myocardial infarction. Journal of the American College of Cardiology, 58(23), 2415\u20132423.", "ArticleIdList": ["22115649"]}, {"Citation": "Jackson, E. K., Zhang, Y., Gillespie, D. D., Zhu, X., Cheng, D., & Jackson, T. C. (2017). SDF-1\u03b1 (Stromal Cell-Derived Factor 1\u03b1) induces cardiac fibroblasts, renal microvascular smooth muscle cells, and glomerular mesangial cells to proliferate, cause hypertrophy, and produce collagen. Journal of the American Heart Association, 6(11), e007253.", "ArticleIdList": ["29114002", "5721794"]}, {"Citation": "Zhou, Z., Subramanian, P., Sevilmis, G., Globke, B., Soehnlein, O., Karshovska, E., et al. (2011). Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium. Cell Metabolism, 13(5), 592\u2013600.", "ArticleIdList": ["21531341"]}, {"Citation": "Fong, A. M., Robinson, L. A., Steeber, D. A., Tedder, T. F., Yoshie, O., Imai, T., et al. (1998). Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. The Journal of Experimental Medicine, 188(8), 1413\u20131419.", "ArticleIdList": ["9782118", "2213407"]}, {"Citation": "Koziolek, M. J., M\u00fcller, G.-A., Zapf, A., Patschan, D., Schmid, H., Cohen, C. D., et al. (2010). Role of CX3C-chemokine CX3C-L/fractalkine expression in a model of slowly progressive renal failure. Nephrology, Dialysis, Transplantation, 25(3), 684\u2013698.", "ArticleIdList": ["19934081"]}, {"Citation": "Sch\u00e4fer, A., Schulz, C., Fraccarollo, D., Tas, P., Leutke, M., Eigenthaler, M., et al. (2007). The CX3C chemokine fractalkine induces vascular dysfunction by generation of superoxide anions. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(1), 55\u201362.", "ArticleIdList": ["17082482"]}, {"Citation": "Wong, B. W., Wong, D., & McManus, B. M. (2002). Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease. Cardiovascular Pathology, 11(6), 332\u2013338.", "ArticleIdList": ["12459434"]}, {"Citation": "Zdrojewski, T., Bandosz, P., Gaciong, Z., & Wyrzykowski, B. (2011). Rozpowszechnienie czynnik\u00f3w ryzyka chor\u00f3b uk\u0142adu sercowo-naczyniowego w Polsce w 2011 r. Zakres wieku, 18\u201379."}, {"Citation": "Shimizu, K., Furuichi, K., Sakai, N., Kitagawa, K., Matsushima, K., Mukaida, N., et al. (2011). Fractalkine and its receptor, CX3CR1, promote hypertensive interstitial fibrosis in the kidney. Hypertension Research, 34(6), 747\u2013752.", "ArticleIdList": ["21451526"]}, {"Citation": "Rius, C., Piqueras, L., Gonz\u00e1lez-Navarro, H., Albertos, F., Company, C., L\u00f3pez-Gin\u00e9s, C., et al. (2013). Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-II. Arteriosclerosis, Thrombosis, and Vascular Biology, 33(1), 96\u2013104.", "ArticleIdList": ["23117657"]}, {"Citation": "Antonelli, A., Fallahi, P., Ferrari, S., Ghiadoni, L., Virdis, A., Mancusi, C., et al. (2012). High serum levels of CXC (CXCL10) and CC (CCL2) chemokines in untreated essential hypertension. International Journal of Immunopathology and Pharmacology, 25(2), 387\u2013395.", "ArticleIdList": ["22697070"]}, {"Citation": "Keeley, E. C., Mehrad, B., Janardhanan, R., Salerno, M., Hunter, J. R., Burdick, M. M., et al. (2012). Elevated circulating fibrocyte levels in patients with hypertensive heart disease. Journal of Hypertension, 30(9), 1856.", "ArticleIdList": ["22796709", "3643814"]}, {"Citation": "Tsai, M.-K., Jan, R.-L., Lin, C.-H., Kuo, C.-H., Yang, S.-N., Chen, H.-N., et al. (2011). Suppressive effects of imidapril on Th1-and Th2-related chemokines in monocytes. Journal of Investigative Medicine, 59(7), 1141\u20131146.", "ArticleIdList": ["21849907"]}, {"Citation": "Banach, M., Patti, A.M., Giglio, R.V., Cicero, A.F.G., Atanasov, A.G., Bajraktari, G., et al. (2018). The Role of Nutraceuticals in Statin Intolerant Patients.\u00a0Journal of the American College of Cardiology, 72(1), 96\u2013118."}, {"Citation": "Pirro, M., Mannarino, M.R., Bianconi, V., Simental-Mend\u00eda, L.E., Bagaglia, F., Mannarino, E., et al. (2016). The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta-analysis of randomized controlled trials (2016) Pharmacological Research, 110, 76\u201388."}, {"Citation": "Shukla, S. K., Gupta, S., Ojha, S. K., & Sharma, S. B. (2010). Cardiovascular friendly natural products: A promising approach in the management of CVD. Natural Product Research, 24(9), 873\u2013898.", "ArticleIdList": ["20461632"]}, {"Citation": "Nikitha, G., & Sandur, R. (2019). Cardioprotective potential of plants and plant-derived principles \u2013 A review. Asian Journal of Pharmaceutical and Clinical Research, 12(3), 46\u201356."}, {"Citation": "Pirro, M., Bagaglia, F., Paoletti, L., Razzi, R., & Mannarino, M. R. (2008). Hypercholesterolemia-associated endothelial progenitor cell dysfunction. Therapeutic Advances in Cardiovascular Disease, 2(5), 329\u2013339.", "ArticleIdList": ["19124431"]}, {"Citation": "Mollazadeh, H., Cicero, A. F., Blesso, C. N., Pirro, M., Majeed, M., & Sahebkar, A. (2019). Immune modulation by curcumin: The role of interleukin-10. Critical Reviews in Food Science and Nutrition, 59(1), 89\u2013101.", "ArticleIdList": ["28799796"]}, {"Citation": "Momtazi, A.A., Derosa, G., Maffioli, P., Banach, M., Sahebkar, A. (2016). Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases. Molecular Diagnosis and Therapy, 20(4), 335\u2013345."}, {"Citation": "Panahi, Y., Ahmadi, Y., Teymouri, M., Johnston, T.P., Sahebkar, A. (2018). Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms (2018). Journal of Cellular Physiology, 233(1), 141\u2013152."}, {"Citation": "Ghandadi, M., Sahebkar, A. (2017). Curcumin: An effective inhibitor of interleukin-6. Current Pharmaceutical Design, 23(6), 921\u2013931."}, {"Citation": "Teymouri, M., Pirro, M., Johnston, T.P., Sahebkar, A. (2017). Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features. BioFactors, 43(3), 331\u2013346."}, {"Citation": "Panahi, Y., Khalili, N., Sahebi, E., Namazi, S., Simental-Mend\u00eda, L.E., Majeed, M., et al. (2018). Effects of Curcuminoids Plus Piperine on Glycemic, Hepatic and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind Placebo-Controlled Trial. Drug Research, 68(7), 403\u2013409."}, {"Citation": "Li, H., Sureda, A., Devkota, H. P., Pittal\u00e0, V., Barreca, D., Silva, A. S., et al. (2020). Curcumin, the golden spice in treating cardiovascular diseases. Biotechnology Advances, 38."}, {"Citation": "Priebe, H. J. (2004). Triggers of perioperative myocardial ischaemia and infarction. British Journal of Anaesthesia, 93(1), 9\u201320.", "ArticleIdList": ["15096440"]}, {"Citation": "Xiao, J., Sheng, X., Zhang, X., Guo, M., & Ji, X. (2016). Curcumin protects against myocardial infarction-induced cardiac fibrosis via SIRT1 activation in vivo and in vitro. Drug Design, Development and Therapy, 10, 1267.", "ArticleIdList": ["27099472", "4820283"]}, {"Citation": "Morimoto, T., Sunagawa, Y., Kawamura, T., Takaya, T., Wada, H., Nagasawa, A., et al. (2008). The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. The Journal of Clinical Investigation, 118(3), 868\u2013878.", "ArticleIdList": ["18292809", "2248328"]}, {"Citation": "Saeidinia, A., Keihanian, F., Butler, A. E., Bagheri, R. K., Atkin, S. L., & Sahebkar, A. (2018). Curcumin in heart failure: A choice for complementary therapy? Pharmacological Research, 131, 112\u2013119.", "ArticleIdList": ["29550354"]}, {"Citation": "Sahebkar, A. (2014). Curcuminoids for the management of hypertriglyceridaemia. Nature Reviews Cardiology, 11(2), 123.", "ArticleIdList": ["24395048"]}, {"Citation": "Sahebkar, A. (2010). Molecular mechanisms for curcumin benefits against ischemic injury. Fertility and Sterility, 94(5), e75\u2013e76.", "ArticleIdList": ["20797714"]}, {"Citation": "Ganjali, S., Blesso, C. N., Banach, M., Pirro, M., Majeed, M., & Sahebkar, A. (2017). Effects of curcumin on HDL functionality. Pharmacological Research, 119, 208\u2013218.", "ArticleIdList": ["28192240"]}, {"Citation": "Panahi, Y., Sahebkar, A., Parvin, S., & Saadat, A. (2012). A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications. Annals of Clinical Biochemistry, 49(6), 580\u2013588.", "ArticleIdList": ["23038702"]}, {"Citation": "Sahebkar, A. (2014). Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytotherapy Research, 28(5), 633\u2013642.", "ArticleIdList": ["23922235"]}, {"Citation": "Arenzana-Seisdedos, F., & Parmentier, M. (2006). Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands. In Seminars in Immunology (Vol. 18, pp. 387\u2013403). Elsevier."}, {"Citation": "Ganjali, S., Sahebkar, A., Mahdipour, E., Jamialahmadi, K., Torabi, S., Akhlaghi, S., et al. (2014). Investigation of the effects of curcumin on serum cytokines in obese individuals: A randomized controlled trial. The Scientific World Journal, 2014."}, {"Citation": "Panahi, Y., Kianpour, P., Mohtashami, R., Jafari, R., Simental-Mend\u00eda, L. E., & Sahebkar, A. (2016). Curcumin lowers serum lipids and uric acid in subjects with nonalcoholic fatty liver disease: A randomized controlled trial. Journal of Cardiovascular Pharmacology, 68(3), 223\u2013229.", "ArticleIdList": ["27124606"]}, {"Citation": "Karimian, M. S., Pirro, M., Majeed, M., & Sahebkar, A. (2017). Curcumin as a natural regulator of monocyte chemoattractant protein-1. Cytokine & Growth Factor Reviews, 33, 55\u201363."}, {"Citation": "Aukrust, P., Berge, R. K., Ueland, T., Aaser, E., Dam\u00e5s, J. K., Wikeby, L., et al. (2001). Interaction between chemokines and oxidative stress: Possible pathogenic role in acute coronary syndromes. Journal of the American College of Cardiology, 37(2), 485\u2013491.", "ArticleIdList": ["11216967"]}, {"Citation": "Mettimano, M., Lucia Specchia, M., La Torre, G., Bruno, A., Ricciardi, G., Savi, L., et al. (2006). Blood pressure regulation by CCR genes. Clinical and Experimental Hypertension, 28(7), 611\u2013618.", "ArticleIdList": ["17060059"]}, {"Citation": "Mettimano, M., Specchia, M., Ianni, A., Arzani, D., Ricciardi, G., Savi, L., et al. (2003). CCR5 and CCR2 gene polymorphisms in hypertensive patients. British Journal of Biomedical Science, 60(1), 19\u201321.", "ArticleIdList": ["12680626"]}, {"Citation": "Chan, C. T., Moore, J. P., Budzyn, K., Guida, E., Diep, H., Vinh, A., et al. (2012). Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone/salt-treated mice. Hypertension, 60(5), 1207\u20131212.", "ArticleIdList": ["23033370"]}, {"Citation": "Mukai, Y., & Sato, S. (2011). Polyphenol-containing azuki bean (Vigna angularis) seed coats attenuate vascular oxidative stress and inflammation in spontaneously hypertensive rats. The Journal of Nutritional Biochemistry, 22(1), 16\u201321.", "ArticleIdList": ["20185287"]}, {"Citation": "Hern\u00e1ndez, M., Wicz, S., & Corral, R. S. (2016). Cardioprotective actions of curcumin on the pathogenic NFAT/COX-2/prostaglandin E2 pathway induced during Trypanosoma cruzi infection. Phytomedicine, 23(12), 1392\u20131400.", "ArticleIdList": ["27765359"]}, {"Citation": "Glaros, T., Larsen, M., & Li, L. (2009). Macrophages and fibroblasts during inflammation, tissue damage and organ injury. Frontiers in Bioscience, 14(10), 3988\u20133993."}, {"Citation": "Lavine, K. J., Epelman, S., Uchida, K., Weber, K. J., Nichols, C. G., Schilling, J. D., et al. (2014). Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. Proceedings of the National Academy of Sciences, 111(45), 16029\u201316034."}, {"Citation": "Leid, J., Carrelha, J., Boukarabila, H., Epelman, S., Jacobsen, S. E., & Lavine, K. J. (2016). Primitive embryonic macrophages are required for coronary development and maturation. Circulation Research, 118(10), 1498\u20131511.", "ArticleIdList": ["27009605", "5567774"]}, {"Citation": "Frantz, S., & Nahrendorf, M. (2014). Cardiac macrophages and their role in ischaemic heart disease. Cardiovascular Research, 102(2), 240\u2013248.", "ArticleIdList": ["24501331", "3989449"]}, {"Citation": "Song, Y., Ge, W., Cai, H., & Zhang, H. (2013). Curcumin protects mice from coxsackievirus B3-induced myocarditis by inhibiting the phosphatidylinositol 3 kinase/Akt/nuclear factor-\u03baB pathway. Journal of Cardiovascular Pharmacology and Therapeutics, 18(6), 560\u2013569.", "ArticleIdList": ["24057864"]}, {"Citation": "Rodr\u00edguez-Iturbe, B., Ferrebuz, A., Vanegas, V., Quiroz, Y., Mezzano, S., & Vaziri, N. D. (2005). Early and sustained inhibition of nuclear factor-\u03baB prevents hypertension in spontaneously hypertensive rats. Journal of Pharmacology and Experimental Therapeutics, 315(1), 51\u201357.", "ArticleIdList": ["15951402"]}, {"Citation": "Nanji, A. A., Jokelainen, K., Tipoe, G. L., Rahemtulla, A., Thomas, P., & Dannenberg, A. J. (2003). Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-\u03baB-dependent genes. American Journal of Physiology-Gastrointestinal and Liver Physiology, 284(2), G321\u2013G327.", "ArticleIdList": ["12388178"]}, {"Citation": "Wang, N.-P., Pang, X.-F., Zhang, L.-H., Tootle, S., Harmouche, S., & Zhao, Z.-Q. (2014). Attenuation of inflammatory response and reduction in infarct size by postconditioning are associated with downregulation of early growth response 1 during reperfusion in rat heart. Shock, 41(4), 346\u2013354.", "ArticleIdList": ["24365880"]}, {"Citation": "Gao, S., Zhou, J., Liu, N., Wang, L., Gao, Q., Wu, Y., et al. (2015). Curcumin induces M2 macrophage polarization by secretion IL-4 and/or IL-13. Journal of Molecular and Cellular Cardiology, 85, 131\u2013139.", "ArticleIdList": ["25944087"]}, {"Citation": "Sunagawa, Y., Morimoto, T., Wada, H., Takaya, T., Katanasaka, Y., Kawamura, T., et al. (2011). A natural p300-specific histone acetyltransferase inhibitor, curcumin, in addition to angiotensin-converting enzyme inhibitor, exerts beneficial effects on left ventricular systolic function after myocardial infarction in rats. Circulation Journal, 75(9), 2151\u20132159.", "ArticleIdList": ["21737953"]}, {"Citation": "S\u00e1nchez-Calvo, J. M., Villegas, I., S\u00e1nchez-Fidalgo, S., Camacho-Barquero, L., Talero, E., Motilva, V., et al. (2009). Protective effect of curcumin, a Curcuma longa constituent, in early colonic inflammation in rats. Drug Development Research, 70(6), 425\u2013437."}, {"Citation": "Saika, F., Kiguchi, N., Kobayashi, D., Matsuzaki, S., & Kishioka, S. (2019). Curcumin attenuates methamphetamine-induced conditioned place preference via an inhibition of CC chemokine ligand 2 expression. In European Neuropsychopharmacology (Vol. 29, pp. S178\u2013S179). Amsterdam: Elsevier Science B.V."}, {"Citation": "Zhang, M., Ardlie, K., Wacholder, S., Welch, R., Chanock, S., & O\u2019Brien, T. R. (2006). Genetic variations in CC chemokine receptors and hypertension. American Journal of Hypertension, 19(1), 67\u201372.", "ArticleIdList": ["16461193"]}, {"Citation": "Gouraud, S. S., Waki, H., Bhuiyan, M. E., Takagishi, M., Cui, H., Kohsaka, A., et al. (2011). Down-regulation of chemokine Ccl5 gene expression in the NTS of SHR may be pro-hypertensive. Journal of Hypertension, 29(4), 732\u2013740.", "ArticleIdList": ["21358418"]}, {"Citation": "Ghosh, S., Banerjee, S., & Sil, P. C. (2015). The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update. Food and Chemical Toxicology, 83, 111\u2013124.", "ArticleIdList": ["26066364"]}, {"Citation": "Um, M. Y., Hwang, K. H., Choi, W. H., Ahn, J., Jung, C. H., & Ha, T. Y. (2014). Curcumin attenuates adhesion molecules and matrix metalloproteinase expression in hypercholesterolemic rabbits. Nutrition Research, 34(10), 886\u2013893.", "ArticleIdList": ["25282128"]}, {"Citation": "Kapakos, G., Youreva, V., & Srivastava, A. K. (2012). Cardiovascular protection by curcumin: Molecular aspects. Indian Journal of Geo-Marine Sciences, 49, 306\u2013315."}, {"Citation": "Zhang, S., Zou, J., Li, P., Zheng, X., & Feng, D. (2018). Curcumin protects against atherosclerosis in apolipoprotein E-knockout mice by inhibiting toll-like receptor 4 expression. Journal of Agricultural and Food Chemistry, 66(2), 449\u2013456.", "ArticleIdList": ["29224353"]}, {"Citation": "Liu, T., Li, C., Sun, H., Luo, T., Tan, Y., Tian, D., et al. (2014). Curcumin inhibits monocyte chemoattractant protein-1 expression and enhances cholesterol efflux by suppressing the c-Jun N-terminal kinase pathway in macrophage. Inflammation Research, 63(10), 841\u2013850.", "ArticleIdList": ["25064633"]}, {"Citation": "Witztum, J. (1989). Beyond cholesterol: Modifications of low density lipoprotein that increase its atherogenicity. The New England Journal of Medicine, 320, 915\u2013924.", "ArticleIdList": ["2648148"]}, {"Citation": "Seino, Y., Ikeda, U., Takahashi, M., Hojo, Y., Irokawa, M., Kasahara, T., et al. (1995). Expression of monocyte chemoattractant protein-1 in vascular tissue. Cytokine, 7(6), 575\u2013579.", "ArticleIdList": ["8580375"]}, {"Citation": "Yl\u00e4-Herttuala, S., Lipton, B. A., Rosenfeld, M. E., S\u00e4rkioja, T., Yoshimura, T., Leonard, E. J., et al. (1991). Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proceedings of the National Academy of Sciences, 88(12), 5252\u20135256."}, {"Citation": "Lim, J. H., & Kwon, T. K. (2010). Curcumin inhibits phorbol myristate acetate (PMA)-induced MCP-1 expression by inhibiting ERK and NF-\u03baB transcriptional activity. Food and Chemical Toxicology, 48(1), 47\u201352.", "ArticleIdList": ["19766691"]}, {"Citation": "Orr, A. W., Hastings, N. E., Blackman, B. R., & Wamhoff, B. R. (2010). Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. Journal of Vascular Research, 47(2), 168\u2013180.", "ArticleIdList": ["19851078"]}, {"Citation": "Rzucidlo, E. M., Martin, K. A., & Powell, R. J. (2007). Regulation of vascular smooth muscle cell differentiation. Journal of Vascular Surgery, 45(6), A25\u2013A32.", "ArticleIdList": ["17544021"]}, {"Citation": "Zhang, Z., Chen, H., Xu, C., Song, L., Huang, L., Lai, Y., et al. (2016). Curcumin inhibits tumor epithelial-mesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in colon cancer cells. Oncology Reports, 35(5), 2615\u20132623.", "ArticleIdList": ["26985708", "4811403"]}, {"Citation": "Aggarwal, B. B. (2010). Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annual Review of Nutrition, 30, 173\u2013199.", "ArticleIdList": ["20420526", "3144156"]}, {"Citation": "Woo, H.-M., Kang, J.-H., Kawada, T., Yoo, H., Sung, M.-K., & Yu, R. (2007). Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes. Life Sciences, 80(10), 926\u2013931.", "ArticleIdList": ["17196622"]}, {"Citation": "Shehzad, A., Ha, T., Subhan, F., & Lee, Y. S. (2011). New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. European Journal of Nutrition, 50(3), 151\u2013161.", "ArticleIdList": ["21442412"]}, {"Citation": "Olivera, A., Moore, T. W., Hu, F., Brown, A. P., Sun, A., Liotta, D. C., et al. (2012). Inhibition of the NF-\u03baB signaling pathway by the curcumin analog, 3, 5-Bis (2-pyridinylmethylidene)-4-piperidone (EF31): Anti-inflammatory and anti-cancer properties. International Immunopharmacology, 12(2), 368\u2013377.", "ArticleIdList": ["22197802"]}, {"Citation": "Bajpai, G., Bredemeyer, A., Li, W., Zaitsev, K., Koenig, A. L., Lokshina, I., et al. (2019). Tissue resident CCR2\u2212 and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury. Circulation Research, 124(2), 263\u2013278.", "ArticleIdList": ["30582448", "6626616"]}, {"Citation": "Heo, G. S., Kopecky, B., Sultan, D., Ou, M., Feng, G., Bajpai, G., et al. (2019). Molecular imaging visualizes recruitment of inflammatory monocytes and macrophages to the injured heart. Circulation Research, 124(6), 881\u2013890.", "ArticleIdList": ["30661445", "6435034"]}, {"Citation": "Shen, Y., Xie, X., Li, Z., Huang, Y., Ma, L., Shen, X., et al. (2017). Interleukin-17-induced expression of monocyte chemoattractant protein-1 in cardiac myocytes requires nuclear factor \u03baB through the phosphorylation of p65. Microbiology and Immunology, 61(7), 280\u2013286.", "ArticleIdList": ["28593659"]}, {"Citation": "Lin, L., Phillips, W. E., & Manning, R. D., Jr. (2009). Intrarenal angiotensin II is associated with inflammation, renal damage, and dysfunction in dahl salt-sensitive hypertension. Journal of the American Society of Hypertension, 3(5), 306\u2013314.", "ArticleIdList": ["20160914", "2770181"]}, {"Citation": "Li, A., Dubey, S., Varney, M. L., Dave, B. J., & Singh, R. K. (2003). IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. The Journal of Immunology, 170(6), 3369\u20133376.", "ArticleIdList": ["12626597"]}, {"Citation": "Boekholdt, S. M., Peters, R. J., Hack, C. E., Day, N. E., Luben, R., Bingham, S. A., et al. (2004). IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: The EPIC-Norfolk prospective population study. Arteriosclerosis, Thrombosis, and Vascular Biology, 24(8), 1503\u20131508.", "ArticleIdList": ["15178568"]}, {"Citation": "Cheng, M., Li, Y., Wu, J., Nie, Y., Li, L., Liu, X., et al. (2008). IL-8 induces imbalances between nitric oxide and endothelin-1, and also between plasminogen activator inhibitor-1 and tissue-type plasminogen activator in cultured endothelial cells. Cytokine, 41(1), 9\u201315.", "ArticleIdList": ["18023202"]}, {"Citation": "Preston, I. R., Hill, N. S., Warburton, R. R., & Fanburg, B. L. (2006). Role of 12-lipoxygenase in hypoxia-induced rat pulmonary artery smooth muscle cell proliferation. American Journal of Physiology\u2014Lung Cellular and Molecular Physiology, 290(2), L367\u2013L374.", "ArticleIdList": ["16199435"]}, {"Citation": "Ghayour-Mobarhan, M., Sahebkar, A., Parizadeh, S. M. R., Moohebati, M., Tavallaie, S., RezaKazemi-Bajestani, S. M., et al. (2008). Antibody titres to heat shock protein 27 are elevated in patients with acute coronary syndrome. International Journal of Experimental Pathology, 89(3), 209\u2013215.", "ArticleIdList": ["18460073", "2525773"]}, {"Citation": "Wellen, K. E., & Hotamisligil, G. S. (2005). Inflammation, stress, and diabetes. The Journal of Clinical Investigation, 115(5), 1111\u20131119.", "ArticleIdList": ["15864338", "1087185"]}, {"Citation": "Nicolls, M. R., Haskins, K., & Flores, S. C. (2007). Oxidant stress, immune dysregulation, and vascular function in type I diabetes. Antioxidants & Redox Signaling, 9(7), 879\u2013889."}, {"Citation": "Jain, S. K., Rains, J., Croad, J., Larson, B., & Jones, K. (2009). Curcumin supplementation lowers TNF-\u03b1, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-\u03b1, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxidants & Redox Signaling, 11(2), 241\u2013249."}, {"Citation": "Steven, S., Frenis, K., Oelze, M., Kalinovic, S., Kuntic, M., Bayo Jimenez, M. T., et al. (2019). Vascular inflammation and oxidative stress: Major triggers for cardiovascular disease. Oxidative Medicine and Cellular Longevity, 2019."}, {"Citation": "Willerson, J. T., & Ridker, P. M. (2004). Inflammation as a cardiovascular risk factor. Circulation, 109(21_suppl_1), II-2\u2013II-10."}, {"Citation": "Baggiolini, M., Moser, B., & Clark-Lewis, I. (1994). Interleukin-8 and related chemotactic cytokines: The Giles Filley lecture. Chest, 105(3), 95S\u201398S.", "ArticleIdList": ["8131628"]}, {"Citation": "Namdari, M., & Eatemadi, A. (2017). Cardioprotective effects of curcumin-loaded magnetic hydrogel nanocomposite (nanocurcumin) against doxorubicin-induced cardiac toxicity in rat cardiomyocyte cell lines. Artificial Cells, Nanomedicine, and Biotechnology, 45(4), 731\u2013739.", "ArticleIdList": ["27924631"]}, {"Citation": "Swamy, A. V., Gulliaya, S., Thippeswamy, A., Koti, B. C., & Manjula, D. V. (2012). Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats. Indian Journal of Pharmacology, 44(1), 73.", "ArticleIdList": ["22345874", "3271544"]}, {"Citation": "Vors, C., Couillard, C., Paradis, M.-E., Gigleux, I., Marin, J., Vohl, M.-C., et al. (2018). Supplementation with resveratrol and curcumin does not affect the inflammatory response to a high-fat meal in older adults with abdominal obesity: A randomized, placebo-controlled crossover trial. The Journal of Nutrition, 148(3), 379\u2013388.", "ArticleIdList": ["29546309"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "4", "Hour": "6", "Minute": "18"}, {"Year": "2022", "Month": "1", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "6", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34981477", "10.1007/978-3-030-73234-9_11"]}}], "PubmedBookArticle": []}